Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
- 1 May 1996
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 347 (9013) , 1438-1442
- https://doi.org/10.1016/s0140-6736(96)91682-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol DependenceAlcohol, Clinical and Experimental Research, 1994
- Clinical Efficacy of the 5‐HT3 Antagonist Ondansetron in Alcohol Abuse and DependenceAlcohol, Clinical and Experimental Research, 1994
- Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptorsEuropean Journal of Pharmacology, 1993
- Gamma‐Hydroxybutyric Acid in the Treatment of Alcohol Dependence: A Double‐Blind StudyAlcohol, Clinical and Experimental Research, 1992
- GABA and Nucleus Accumbens Glutamate Neurotransmission Modulate Ethanol Self‐Administration in RatsaAnnals of the New York Academy of Sciences, 1992
- Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised ratsPharmacology Biochemistry and Behavior, 1992
- Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animalsPharmacology Biochemistry and Behavior, 1989
- A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved?Pharmacology Biochemistry and Behavior, 1984
- Bromocriptine in the prevention of alcohol abuseActa Psychiatrica Scandinavica, 1983
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960